Home NDC 71687-3003 Pamprin Multi-Symptom
Product NDC 71687-3003
11-digit product format 716873003
Labeler code 71687
Product ID 71687-3003_4fe8f1cd-8250-e908-e063-6394a90a1173
Type HUMAN OTC DRUG
Nonproprietary name Acetaminophen, Pamabrom, Pyrilamine maleate
Dosage form TABLET
Route ORAL
Labeler Focus Consumer Healthcare, LLC
Application M013
Marketing category OTC MONOGRAPH DRUG
Marketing start 2016-06-01
Substance PYRILAMINE MALEATE; PAMABROM; ACETAMINOPHEN
Active strength 15; 25; 500 mg/1; mg/1; mg/1
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 21 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Code Status Snapshot Source SHA-256 2025-04-01 02:39 UTC · source 2025-03-31 excluded product product I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 71687-3003-4 I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 71687-3003-1 I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 71687-3003-4 I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 71687-3003-1 I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 71687-3003-4 I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 71687-3003-1 I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 71687-3003-4 I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 71687-3003-1 I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product U Excluded because listing certification expired 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 71687-3003-4 U Excluded because listing certification expired 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 71687-3003-1 U Excluded because listing certification expired 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product U Excluded because listing certification expired ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 71687-3003-4 U Excluded because listing certification expired ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 71687-3003-1 U Excluded because listing certification expired ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product U Excluded because listing certification expired 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 71687-3003-4 U Excluded because listing certification expired 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 71687-3003-1 U Excluded because listing certification expired 0efc9e666f02…f202fb6c5f17…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Pamprin Multi-Symptom
Brand name suffix Maximum Strength
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength PYRILAMINE MALEATE 15 mg/1 PAMABROM 25 mg/1 ACETAMINOPHEN 500 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 3 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination R35D29L3ZA Internal UNII lookup UA8U0KJM72 Internal UNII lookup 362O9ITL9D Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1052637 Internal RxNorm lookup 1053852 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 71687-3003-1 Pamprin Multi-SymptomMaximum Strength 20 in 1 BOTTLE, PLASTIC TABLET 20 5 71687-3003-1 Pamprin Multi-SymptomMaximum Strength 1 in 1 CARTON TABLET 1 5 71687-3003-4 Pamprin Multi-SymptomMaximum Strength 1 in 1 CARTON TABLET 1 5 71687-3003-4 Pamprin Multi-SymptomMaximum Strength 40 in 1 BOTTLE, PLASTIC TABLET 40 5
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 71687-3003 PAMPRIN MULTI-SYMPTOM MAXIMUM STRENGTH (ACETAMINOPHEN, PAMABROM, PYRILAMINE MALEATE) TABLET [FOCUS CONSUMER HEALTHCARE, LLC] 4 Current NDC, Legacy NDC, 4 package rows 20250416_60b3286d-5698-df50-e053-2991aa0afbe2.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 22 of 83 · 1,657 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join basic care aspirin ASPIRIN Amazon.com Services LLC 265c7d85-a666-4234-9c30-ca8e31f4bcb8 2026-02-03 Warnings Exact identifier application number: M013 GOODYS MAX ACETAMINOPHEN, ASPIRIN, AND CAFFEINE Medtech Products Inc. 02b3a604-3f09-47e7-add1-b9038b3a268b 2026-02-02 Warnings Exact identifier application number: M013 Nighttime Pain Reliever plus Sleep Aid ACETAMINOPHEN, DIPHENHYDRAMINE HCL WALMART INC. 8dd85a6b-507c-4502-9e55-a40bdf21d379 2026-02-02 Warnings Exact identifier application number: M013 Pain Reliever ACETAMINOPHEN Rite Aid Corporation 9a647967-f0c6-466e-be70-34fd3de0a803 2026-02-02 Warnings Exact identifier application number: M013 Pain Reliever Extra Strength ACETAMINOPHEN Wal-Mart Stores Inc 72365264-f9c4-49f0-be64-73d95817d358 2026-02-02 Warnings Exact identifier application number: M013 Acetaminophen 325mg ACETAMINOPHEN Marlex Pharmaceuticals Inc 4a18168c-dd36-8280-e063-6394a90a7e10 2026-02-01 Warnings Exact identifier application number: M013 Acetaminophen ACETAMINOPHEN Marlex Pharmaceuticals Inc 4a183b7d-3a1e-5557-e063-6294a90a5493 2026-02-01 Warnings Exact identifier application number: M013 Mejoralito Children CHILDREN ACETAMINOPHEN OPMX LLC 499e2334-fe7b-ed75-e063-6294a90a3e4c 2026-01-30 Warnings Exact identifier application number: M013 Resfriol-ito Children ACETAMINOPHEN OPMX LLC 49a27970-f497-934d-e063-6394a90a08d9 2026-01-30 Warnings Exact identifier application number: M013 DOLODOL ACETAMINOPHEN, ASPIRIN, CAFFEINE OPMX LLC 4c3544bb-058d-4585-e063-6394a90a79f4 2026-01-30 Warnings Exact identifier application number: M013 ATAMEL Forte ACETAMINOPHEN OPMX LLC 4988c97a-af39-16a8-e063-6294a90a8993 2026-01-29 Warnings Exact identifier application number: M013 EXTRA STRENGTH PAIN RELEIF ACETAMINOPHEN Strategic Sourcing Services, LLC 0392db17-c4f3-424b-9dee-549fc5df61c5 2026-01-29 Warnings Exact identifier application number: M013 Regular Strength Pain Reliever ACETAMINOPHEN Strategic Sourcing Services, LLC 959db1b0-2d9f-4857-b475-0fa027365212 2026-01-29 Warnings Exact identifier application number: M013 ASPIRIN ASPIRIN Strategic Sourcing Services LLC 8acdbcf9-64a0-4dda-b60e-7e122254ecf3 2026-01-29 Warnings Exact identifier application number: M013 Crocin MAX ACETAMINOPHEN OPMX LLC 498c7d7e-d952-c122-e063-6394a90ae72f 2026-01-29 Warnings Exact identifier application number: M013 DOLONEURO-TROPAS ACETAMINOPHEN, CAFFEINE OPMX LLC 4c4b0d8c-3195-7d7b-e063-6294a90a8c42 2026-01-29 Warnings Exact identifier application number: M013 Acetaminophen Extra Strength ACETAMINOPHEN FOODHOLD U.S.A., LLC bc19bd47-69ea-4bcc-8d28-c043c9d32513 2026-01-29 Warnings Exact identifier application number: M013 Alka-Seltzer Pain Relief ALKA-SELTZER PAIN RELIEF Bayer HealthCare LLC. 4975f0ff-0480-7fca-e063-6294a90aef2f 2026-01-28 Warnings Exact identifier application number: M013 Extra Strength Mini Softgels Pain Reliever ACETAMINOPHEN THE KROGER CO b49aae4f-b040-44a0-be73-cdf45cf14d7e 2026-01-28 Warnings Exact identifier application number: M013 Extra Strength Acetaminophen ACETAMINOPHEN Preferred Pharmaceuticals Inc. b25faa8c-2d13-450a-970f-81c17a633030 2026-01-28 Warnings Exact identifier application number: M013
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 71687-3003-1 71687300301 1 BOTTLE, PLASTIC in 1 CARTON (71687-3003-1) / 20 TABLET in 1 BOTTLE, PLASTIC 2016-06-01 0000-00-00 No No Current 71687-3003-4 71687300304 1 BOTTLE, PLASTIC in 1 CARTON (71687-3003-4) / 40 TABLET in 1 BOTTLE, PLASTIC 2016-06-01 0000-00-00 No No Current